{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:22:25Z","timestamp":1790144545781,"version":"4.0.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gray zone lymphoma (GZL), a B-cell lymphoma with features intermediate between large B-cell lymphoma (LBCL) and classic Hodgkin lymphoma (cHL), is a rare and poorly defined entity. Alongside GZL, a subset of Epstein-Barr virus (EBV)\u2013positive diffuse large B-cell lymphoma (DLBCL) has been described with polymorphic\/GZL-like morphology (polymorphic-EBV-L). To fill the important gap in our understanding of the pathogenic process underlying these entities, we performed a gene expression study of a large international cohort of GZL and polymorphic-EBV-L, combined with cHL and primary mediastinal large B-cell lymphoma (PMBCL) cases. In an unsupervised principal component analysis, GZL cases presented with intermediate scores in a spectrum between cHL and PMBCL, whereas polymorphic-EBV-L clustered distinctly. The main biological pathways underlying the GZL spectrum were related to cell cycle, reflecting tumor cell content, and extracellular matrix signatures related to the cellular tumor microenvironment. Differential expression analysis and phenotypic characterization of the tumor microenvironment highlighted the predominance of regulatory macrophages in GZL compared with cHL and PMBCL. Two distinct subtypes of GZL were distinguishable that were phenotypically reminiscent of PMBCL and DLBCL, and we observed an association of PMBCL-type GZL with clinical presentation in the \u201cthymic\u201d anatomic niche. In summary, gene expression profiling (GEP) enabled us to add precision to the GZL spectrum, describe the biological distinction compared with polymorphic-EBV-L, and distinguish cases with and without thymic involvement as 2 subgroups of GZL, namely PMBCL-like and DLBCL-like GZL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001923","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T15:36:19Z","timestamp":1591716979000},"page":"2523-2535","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["Gene expression profiling of gray zone lymphoma"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-9304","authenticated-orcid":false,"given":"Cl\u00e9mentine","family":"Sarkozy","sequence":"first","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche (UMR)-S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France;"},{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Chong","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chavez","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyata-Takata","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben","family":"Duns","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Telenius","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill","family":"Boyle","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Slack","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Laurent","sequence":"first","affiliation":[{"name":"Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire Toulouse, INSERM U.1037, Centre de Recherche en Cancerologie de Toulouse-Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-9391","authenticated-orcid":false,"given":"Pedro","family":"Farinha","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry J.","family":"Molina","sequence":"first","affiliation":[{"name":"Pathology Department, Necker Enfants Malades Hospital, Universit\u00e9 Paris Descartes, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Copie-Bergman","sequence":"first","affiliation":[{"name":"Pathology Department, Henri Mondor-Albert Chennevier Hospital, AP-HP, Paris Est-Cr\u00e9teil (UPEC) University, UMR-S 955, INSERM, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"first","affiliation":[{"name":"D\u00e9partement de Pathologie, Groupe Hospitalier Cochin, AP-HP, Paris Descartes University-Sorbonne, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-8666","authenticated-orcid":false,"given":"Gilles A.","family":"Salles","sequence":"first","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche (UMR)-S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France;"},{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'H\u00e9matologie, Pierre B\u00e9nite Cedex, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mottok","sequence":"first","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-9863","authenticated-orcid":false,"given":"Kerry J.","family":"Savage","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"first","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche (UMR)-S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France;"},{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d\u2019Anatomie Pathologique, Pierre B\u00e9nite Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"issue":"20","key":"2020060911360743300_B1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020060911360743300_B2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/joim.12633","article-title":"Genetic landscape and deregulated pathways in B-cell lymphoid malignancies","volume":"282","author":"Rosenquist","year":"2017","journal-title":"J Intern Med"},{"key":"2020060911360743300_B3","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin\u2019s disease and related diseases (\u201cgrey zone\u201d lymphoma)","volume":"9","author":"R\u00fcdiger","year":"1998","journal-title":"Ann Oncol"},{"issue":"6","key":"2020060911360743300_B4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"2020060911360743300_B5","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2020060911360743300_B6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020060911360743300_B7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2020060911360743300_B8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone lymphoma between cHL and large B-Cell lymphoma: a histopathologic series from the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020060911360743300_B9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/his.13100","article-title":"Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases","volume":"70","author":"Elsayed","year":"2017","journal-title":"Histopathology"},{"issue":"7","key":"2020060911360743300_B10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/pin.12175","article-title":"Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study","volume":"64","author":"Elsayed","year":"2014","journal-title":"Pathol Int"},{"issue":"1","key":"2020060911360743300_B11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","article-title":"Large B-cell lymphoma with Hodgkin\u2019s features","volume":"47","author":"Garc\u00eda","year":"2005","journal-title":"Histopathology"},{"issue":"5","key":"2020060911360743300_B12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/modpathol.2011.200","article-title":"The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases","volume":"25","author":"Gualco","year":"2012","journal-title":"Mod Pathol"},{"issue":"26","key":"2020060911360743300_B13","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"issue":"15","key":"2020060911360743300_B14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2017-09-772632","article-title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","volume":"131","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020060911360743300_B15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2020060911360743300_B16","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1111\/j.1468-3083.2012.04653.x","article-title":"Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma","volume":"27","author":"Emri","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2020060911360743300_B17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/toxsci\/52.2.199","article-title":"Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control","volume":"52","author":"Youn","year":"1999","journal-title":"Toxicol Sci"},{"issue":"22","key":"2020060911360743300_B18","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2020060911360743300_B19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"32","key":"2020060911360743300_B20","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1200\/JCO.2017.72.7925","article-title":"Prognostic model to predict post-autologous stem-cell transplantation outcomes in classical Hodgkin lymphoma","volume":"35","author":"Chan","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020060911360743300_B21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2020060911360743300_B22","doi-asserted-by":"crossref","first-page":"e87066","DOI":"10.1371\/journal.pone.0087066","article-title":"CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma","volume":"9","author":"Koh","year":"2014","journal-title":"PLoS One"},{"issue":"16","key":"2020060911360743300_B23","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"2020060911360743300_B24","article-title":"Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma [published online ahead of print 30 March 2020]","author":"Pittaluga","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"2020060911360743300_B25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"2020060911360743300_B26","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2020060911360743300_B27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3324\/haematol.2015.124008","article-title":"Tumor-associated macrophages in diffuse large B-cell lymphoma","volume":"100","author":"Kridel","year":"2015","journal-title":"Haematologica"},{"issue":"18","key":"2020060911360743300_B28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin\u2019s lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"2020060911360743300_B29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"2020060911360743300_B30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc1704767","article-title":"PD-1 blockade in mediastinal gray-zone lymphoma","volume":"377","author":"Melani","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2020060911360743300_B31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V69.4.1087.1087","article-title":"Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation","volume":"69","author":"M\u00f6ller","year":"1987","journal-title":"Blood"},{"issue":"3","key":"2020060911360743300_B32","first-page":"411","article-title":"The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression","volume":"59","author":"M\u00f6ller","year":"1986","journal-title":"Immunology"},{"issue":"4","key":"2020060911360743300_B33","doi-asserted-by":"crossref","first-page":"e1295202","DOI":"10.1080\/2162402X.2017.1295202","article-title":"HLA dependent immune escape mechanisms in B-cell lymphomas: implications for immune checkpoint inhibitor therapy?","volume":"6","author":"Nijland","year":"2017","journal-title":"OncoImmunology"},{"issue":"6","key":"2020060911360743300_B34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"12","key":"2020060911360743300_B35","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2020060911360743300_B36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"12","key":"2020060911360743300_B37","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome","volume":"113","author":"Chetaille","year":"2009","journal-title":"Blood"},{"issue":"17","key":"2020060911360743300_B38","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2020060911360743300_B39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/ejh.13274","article-title":"The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma","volume":"103","author":"Keane","year":"2019","journal-title":"Eur J Haematol"},{"issue":"MAR","key":"2020060911360743300_B40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2018.00556","article-title":"Adoptive T cell therapy for Epstein-Barr virus complications in patients with primary immunodeficiency disorders","volume":"9","author":"McLaughlin","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"2020060911360743300_B41","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jcyt.2019.03.569","article-title":"CD19 chimeric antigen receptor (CAR) engineered Epstein-Barr virus (EBV) specific T cells\u2014an off-the-shelf, allogeneic CAR T-cell immunotherapy platform","volume":"21","author":"Shen","year":"2019","journal-title":"Cytotherapy"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2523\/1744197\/advancesadv2020001923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2523\/1744197\/advancesadv2020001923.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T15:36:50Z","timestamp":1591717010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/11\/2523\/460732\/Gene-expression-profiling-of-gray-zone-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,6,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001923","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]}}}